Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

Akshaya Kumar is crisis advocacy director at Human Rights Watch.

Canadians are increasingly frustrated as supply disruptions delay when they will get access to the COVID-19 vaccine. Europe’s dramatic announcement that it would control when and how vaccines produced in their region can be exported to 100 countries, including Canada, adds to existing concerns about delayed deliveries.

Amid this scramble, it is easy to lose sight of the fact that in other parts of the world, vaccines are not available at all. Bloomberg reports that while more than 100 million doses of COVID-19 vaccines have been administered worldwide, fewer than 100 of those were given to people living in low-income countries. Some people may not see COVID-19 vaccines until 2024.

Story continues below advertisement

Canada donates generously to the COVAX program, a public-private partnership set up to facilitate vaccine distribution globally. COVAX, which is reliant on wealthy countries and donors to meet its ambitious budget, aims to supply poorer countries with vaccines for 20 per cent of their populations by the end of this year.

This will leave many countries that cannot currently afford to buy vaccines directly from manufacturers with a huge gap between vaccine supply and demand. Even those that find a way to finance purchases will find limited options since wealthy countries have purchased and reserved most available stock.

Canada, for example, has booked enough doses for five times its population. Prime Minister Justin Trudeau, U.S. President Joe Biden, and policy-makers from the European Union have discussed donating “extra” or “surplus” doses to people in the developing world. However, it’s not clear which vaccines they’re offering to share, or when. What is clear is that donations alone, from Canada or others, won’t be enough.

A better solution is available. Human Rights Watch and many others are supporting a proposal by South Africa and India to waive some intellectual property rights for medical products until “widespread vaccination is in place globally.” The World Trade Organization meets Thursday to consider the idea but Canada is sitting on its hands. It has not joined the more than 100 countries and scores of civil society organizations supporting the proposal to temporarily waive some provisions of the Trade-Related Aspects of the Intellectual Property Rights, or TRIPS, agreement.

Sharing the recipe for vaccines by pooling intellectual property and issuing global, open and non-exclusive licences could help scale-up manufacturing and expand the number of vaccine doses made. This means instead of arguing about how to ration better, we could be rationing less.

This is not a question of morals versus money. While the approach might cut into a few pharmaceutical companies’ bottom lines, it has the potential to actually boost the broader global economy. A new study, which was funded by the International Chamber of Commerce, concluded that vaccine inequity and delays in vaccinating the developing world could cost the global economy US$9.2-trillion, half of which would be borne by advanced economies even after they successfully vaccinated their entire populations.

COVID-19 vaccines have the potential to become a new battleground for great power competition and “vaccine diplomacy.” China and Russia have been offering the developing world priority access to their formulas. India and New Zealand have said they will donate vaccines to neighbours.

Story continues below advertisement

A global movement, including more than 140 world leaders as well as COVID-19 survivors and loved ones of those who died, is calling for a “people’s vaccine.” Mr. Trudeau voiced early support of these efforts, but in practice Canada’s actions have not helped make the vaccine a global public good.

The COVID-19 pandemic has triggered an unprecedented human-rights crisis, with at least 102 million infected, 2.2 million losing their lives, and many more continuing to suffer long-term COVID-19 symptoms. Millions have been pushed into extreme poverty as economies collapsed. Women and children were subjected to higher rates of violence in the home.

Autocrats used the pandemic to cement their power. Asylum seekers looking for refuge across borders were stopped. Scientists rose to this challenge, developing a vaccine at record speed. But governments have failed to set up safeguards to ensure these vaccines are available to all.

There’s still time to change course. Canada should throw its support behind the TRIPS waiver proposal at the World Trade Organization. Ignoring the vaccine needs of the world’s poor wouldn’t just be a public-health failure, it’s also the type of inequity that we should deem intolerable.

Keep your Opinions sharp and informed. Get the Opinion newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies